Chronic hypertension invasive therapy

Jump to navigation Jump to search

Chronic Hypertension Microchapters

Home

2017 ACC/AHA Hypertension Guidelines

Patient Information

Overview

Definition

Classification

Pathophysiology

Causes

Differentiating Hypertension from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Blood Pressure Measurement

Physical Examination

Laboratory Findings

Electrocardiogram

ETT

Echocardiography

CT

MRI

Other Diagnostic Studies

Treatment

Lifestyle Modification

Medical Therapy

Practice Guidelines

Case Studies

Case #1

Chronic hypertension invasive therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chronic hypertension invasive therapy

CDC on Chronic hypertension invasive therapy

Chronic hypertension invasive therapy in the news

Blogs on Chronic hypertension invasive therapy

Directions to Hospitals Treating Chronic hypertension invasive therapy

Risk calculators and risk factors for Chronic hypertension invasive therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Robert G. Badgett, M.D.[2]

Renal artery vascular procedures

Renal artery bypassing and stenting of atherosclerotic disease have been proposed, studied, and eventual found to be not beneficial except in unusual circumstances.[1]

Renal artery denervation

Renal denervation for resistant hypertension also has been found not to be beneficial.[2]

Central arteriovenous anastomosis

More recently central arteriovenous anastomosis has been studied and shows benefit in one trial.[3]

References

  1. GitHub Contributors. Stenting for renal artery stenosis to prevent cardiovascular complications: a living systematic review. GitHub. Available at https://github.com/openMetaAnalysis/Stenting-for-renal-artery-stenosis. Accessed July 23, 2017.
  2. Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT; et al. (2014). "A controlled trial of renal denervation for resistant hypertension". N Engl J Med. 370 (15): 1393–401. doi:10.1056/NEJMoa1402670. PMID 24678939. Review in: Evid Based Med. 2014 Dec;19(6):227-8
  3. Lobo MD, Sobotka PA, Stanton A, Cockcroft JR, Sulke N, Dolan E; et al. (2015). "Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension (the ROX CONTROL HTN study): a randomised controlled trial". Lancet. 385 (9978): 1634–41. doi:10.1016/S0140-6736(14)62053-5. PMID 25620016.

Template:WH Template:WS